Vogel WM - Search Results

1

Coronary sinus occlusion: effect on ischemic left ventricular dysfunction and reactive hyperemia.

Jacobs AK, Faxon DP, Coats WD, Vogel WM, Ryan TJ. Jacobs AK, et al. Among authors: vogel wm. Am Heart J. 1991 Feb;121(2 Pt 1):442-9. doi: 10.1016/0002-8703(91)90710-y. Am Heart J. 1991. PMID: 1990747 Free article.

2

Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.

Vogel WM, Zannoni VG, Abrams GD, Lucchesi BR. Vogel WM, et al. Circulation. 1977 Apr;55(4):588-95. doi: 10.1161/01.cir.55.4.588. Circulation. 1977. PMID: 837501

3

Inhibition of long-chain acylcarnitine accumulation during coronary artery occlusion does not alter infarct size in dogs.

Vogel WM, Bush LR, Cavallo GC, Heathers GP, Hirkaler GM, Kozak MZ, Higgins AJ. Vogel WM, et al. J Cardiovasc Pharmacol. 1994 May;23(5):826-32. doi: 10.1097/00005344-199405000-00020. J Cardiovasc Pharmacol. 1994. PMID: 7521468

4

An isolated, blood-perfused, feline heart preparation for evaluating pharmacological interventions during myocardial ischemia.

Vogel WM, Lucchesi BR. Vogel WM, et al. J Pharmacol Methods. 1980 Dec;4(4):291-303. doi: 10.1016/0160-5402(80)90049-2. J Pharmacol Methods. 1980. PMID: 7206737 Free article.

5

Methylprednisolone sodium succinate treatment in global ischemia of the cat isolated heart.

Vogel WM, Lum D, Lucchesi BR. Vogel WM, et al. J Cardiovasc Pharmacol. 1979 Jan-Feb;1(1):53-68. doi: 10.1097/00005344-197901000-00006. J Cardiovasc Pharmacol. 1979. PMID: 94382

6

Renal and Hematologic Comparative Effects of Dissociated Agonist of the Glucocorticoid Receptor and Prednisone in Dogs With and Without Food Restriction.

Radi ZA, Vogel WM, LaBranche T, Dybowski JA, Peraza MA, Portugal SS, Lettiere DJ. Radi ZA, et al. Among authors: vogel wm. Int J Toxicol. 2018 May/Jun;37(3):223-233. doi: 10.1177/1091581818763804. Epub 2018 Mar 19. Int J Toxicol. 2018. PMID: 29554821

7

Immunologic effects of chronic administration of tofacitinib, a Janus kinase inhibitor, in cynomolgus monkeys and rats - Comparison of juvenile and adult responses.

Collinge M, Ball DJ, Bowman CJ, Nilson AL, Radi ZA, Vogel WM. Collinge M, et al. Among authors: vogel wm. Regul Toxicol Pharmacol. 2018 Apr;94:306-322. doi: 10.1016/j.yrtph.2018.02.006. Epub 2018 Feb 15. Regul Toxicol Pharmacol. 2018. PMID: 29454012

8

Cellular and functional actions of tofacitinib related to the pathophysiology of hibernoma development.

Radi ZA, Vogel WM, Bartholomew PM, Koza-Taylor P, Papanikolaou A, Wisialowski T, Nambiar P, Ball DJ. Radi ZA, et al. Among authors: vogel wm. Regul Toxicol Pharmacol. 2017 Dec;91:93-102. doi: 10.1016/j.yrtph.2017.10.020. Epub 2017 Oct 23. Regul Toxicol Pharmacol. 2017. PMID: 29074274

9

Mechanistic investigations of test article-induced pancreatic toxicity at the endocrine-exocrine interface in the rat.

Brenneman KA, Ramaiah SK, Rohde CM, Messing DM, O'Neil SP, Gauthier LM, Stewart ZS, Mantena SR, Shevlin KM, Leonard CG, Sokolowski SA, Lin H, Carraher DC, Jesson MI, Tomlinson L, Zhan Y, Bobrowski WF, Bailey SA, Vogel WM, Morris DL, Whiteley LO, Davis JW 2nd. Brenneman KA, et al. Among authors: vogel wm. Toxicol Pathol. 2014 Jan;42(1):229-42. doi: 10.1177/0192623313508851. Epub 2013 Nov 13. Toxicol Pathol. 2014. PMID: 24226507

10

Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.

Radi Z, Bartholomew P, Elwell M, Vogel WM. Radi Z, et al. Among authors: vogel wm. Toxicol Appl Pharmacol. 2013 Dec 15;273(3):456-63. doi: 10.1016/j.taap.2013.10.011. Epub 2013 Oct 18. Toxicol Appl Pharmacol. 2013. PMID: 24141031 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page